Jun 14, 2022Vestaron expands leadership team with new hires
Vestaron has announced three new additions to its leadership team: Juan Estupinan, as chief financial officer; Dawn de los Santos, as vice president ofpeople; and Jeff Tuckis as vice president, corporate development.
This announcement comes on the heels of recent news of Vestaron’s Series C funding close at $82 million, an indicator of the company’s commitment to continued growth, innovation and sustainability.
As VP People, Dawn de los Santos will be responsible for leading Vestaron’s people strategy and programs. She will partner with leadership to execute the company’s growth strategy by leading talent acquisition efforts, driving goal alignment, and building a sustainable culture. De los Santos has a broad and diverse HR background in both large, public companies and small/midsize private companies. She began her career in the Thermo Fisher Scientific’s Biosciences division, partnering with business leaders and driving HR functional excellence. More recently, as the VP HR, she built the HR function for an early-stage start-up and led all talent initiatives at a midsize biopharma company. Dawn received her Bachelor of Science from Northern Illinois University, and Master of Business Administration from Northwestern University, Kellogg school of Management.
As VP Corporate Development, Jeff Tuckis will be responsible for identifying partnerships and strategies in consumer lawn and garden, animal health, and the public health markets. He will also help define Vestaron’s strategy in Europe. Tuckis has 20+ years of experience within life sciences including previous Corporate Development roles with Elanco Animal Health and Syngenta Biotech. Tuckis has an Master of Business Administration as well as a Master of Science in Molecular Genetics & Microbiology from the University of Florida.
“These three new hires are key to Vestaron’s continued expansion of products and new markets. With their extensive experience in agriculture and beyond, Juan, Dawn and Jeff will round out our leadership and help set a course for Vestaron’s continued growth,” said Vestaron CEO Anna Rath. “This paired with the announcement of our Series C funding gives the company amazing momentum as we head into summer 2022 introducing The Power of Peptides to more and more markets!”